Evaluation of a New Homogeneous Immunoassay for Quantification of Prothrombin Fragment 1+2 (F1+2)

Prothrombin fragment F1+2 aids in the risk assessment of thrombosis and efficacy of anticoagulant treatment monitoring. Now for the first time, LOCI^® technology* is being used to deliver an improved testing method for the measurement of F1+2. Watch a short video and learn how this assay^† has the potential to offer:
 

• The first and only automated determination of F1+2
• Excellent sensitivity and precision
• A dynamic assay measuring range of up to 5000 pmol/L